Literature DB >> 25265105

Surgical management of symptomatic hydatid liver disease: experience from a Western centre.

Guillaume Martel1, Salima Ismail1, André Bégin1, Franck Vandenbroucke-Menu1, Réal Lapointe1.   

Abstract

BACKGROUND: Hydatid liver cysts are rare in North America. The objective of this study was to determine the optimal surgical management for hydatid liver cysts treated outside endemic areas.
METHODS: We reviewed the cases of consecutive patients who underwent management of hydatid liver cysts. Radical liver resections were compared with other types of procedures. Clinical presentation, investigations, perioperative outcomes and longterm follow-up were evaluated. We evaluated disease recurrence using the Kaplan- Meier method.
RESULTS: Forty patients underwent surgery for hydatid liver cysts. Most patients had single (68%) right-sided (46%) cysts with a median size of 10 cm. Most (83%) underwent liver resection with or without drainage/marsupialization. Radical liver resection was carried out in 60% (19 major, 5 minor). Additional procedures were required in 50% (biliary fistulization 30%, diaphragmatic fistulization 20% or paracaval location/ fusion 8%). Postoperative complications occurred in 48%. The median follow-up was 39 months. The 3-year recurrence-free survival was significantly different between patients who had radical resection and those who had other procedures (100% v. 71%, p = 0.002).
CONCLUSION: The surgical management of hydatid liver cysts in North America remains rare and challenging and is frequently associated with fistulizing complications. Excellent long-term outcomes are best achieved using principles of radical liver resection that are familiar to North American surgeons.

Entities:  

Mesh:

Year:  2014        PMID: 25265105      PMCID: PMC4183678          DOI: 10.1503/cjs.024613

Source DB:  PubMed          Journal:  Can J Surg        ISSN: 0008-428X            Impact factor:   2.089


  19 in total

1.  Hydatid disease of the liver: a continuing surgical problem.

Authors:  Michael C Safioleas; Evangelos P Misiakos; Maria Kouvaraki; Michael K Stamatakos; Christine P Manti; Evangelos S Felekouras
Journal:  Arch Surg       Date:  2006-11

2.  Combined resection of the liver and the inferior vena cava for hydatid disease.

Authors:  Kristin L Mekeel; Alan W Hemming
Journal:  J Gastrointest Surg       Date:  2007-12       Impact factor: 3.452

3.  Predictive factors of deep abdominal complications after operation for hydatid cyst of the liver: 15 years of experience with 672 patients.

Authors:  Hadj Omar El Malki; Yasser El Mejdoubi; Amine Souadka; Raouf Mohsine; Lahcen Ifrine; Redouane Abouqal; Abdelkader Belkouchi
Journal:  J Am Coll Surg       Date:  2008-01-28       Impact factor: 6.113

4.  Guidelines for treatment of cystic and alveolar echinococcosis in humans. WHO Informal Working Group on Echinococcosis.

Authors: 
Journal:  Bull World Health Organ       Date:  1996       Impact factor: 9.408

5.  Surgical treatment of hydatid disease of the liver. A 20-year experience.

Authors:  P Magistrelli; R Masetti; R Coppola; A Messia; G Nuzzo; A Picciocchi
Journal:  Arch Surg       Date:  1991-04

6.  Surgical treatment of hydatid disease of the liver: review of 304 cases.

Authors:  A A Balik; M Başoğlu; F Celebi; D Oren; K Y Polat; S S Atamanalp; M N Akçay
Journal:  Arch Surg       Date:  1999-02

7.  Surgical management and long-term outcome of complicated liver hydatid cysts caused by Echinococcus granulosus.

Authors:  Roland Chautems; Leo H Bühler; Benjamin Gold; Emile Giostra; Pierre Poletti; Michael Chilcott; Philippe Morel; Gilles Mentha
Journal:  Surgery       Date:  2005-03       Impact factor: 3.982

8.  Is hepatic resection the best treatment for hydatid cyst?

Authors:  David Jérémie Birnbaum; Jean Hardwigsen; Louise Barbier; Nizar Bouchiba; Yves Patrice Le Treut
Journal:  J Gastrointest Surg       Date:  2012-08-18       Impact factor: 3.452

9.  Diagnosis and management of hydatid disease of the liver. A 15-year North American experience.

Authors:  J C Langer; D B Rose; J S Keystone; B R Taylor; B Langer
Journal:  Ann Surg       Date:  1984-04       Impact factor: 12.969

10.  Surgical treatment of hydatid cysts of the liver in the era of percutaneous treatment.

Authors:  Kaya Yorganci; Iskender Sayek
Journal:  Am J Surg       Date:  2002-07       Impact factor: 2.565

View more
  6 in total

1.  Pattern of Relapse in Hepatic Hydatidosis: Analysis of 238 Cases in a Single Hospital.

Authors:  Isabel Jaén-Torrejimeno; Diego López-Guerra; Aranzazu Prada-Villaverde; Gerardo Blanco-Fernández
Journal:  J Gastrointest Surg       Date:  2019-02-26       Impact factor: 3.452

2.  Hydatid Cyst of the Liver: A Challenge that can be Amplified Shifting from Open to Laparoscopic Surgery.

Authors:  Adriana Toro; Elena Schembari; Edoardo Mattone; Isidoro Di Carlo
Journal:  World J Surg       Date:  2018-09       Impact factor: 3.352

3.  Epidemiology and Clinical Features of Hydatid Cyst in Northern Iran from 2005 to 2015.

Authors:  Parisa Islami Parkoohi; Marjan Jahani; Fatemeh Hosseinzadeh; Shokufeh Taghian; Forugh Rostami; Abdollah Mousavi; Mohammad Sadegh Rezai
Journal:  Iran J Parasitol       Date:  2018 Apr-Jun       Impact factor: 1.012

4.  Surgical approaches to hepatic hydatidosis ranging from partial cystectomy to liver transplantation.

Authors:  Sanjay Goja; Sujeet Kumar Saha; Sanjay Kumar Yadav; Anisha Tiwari; Arvinder Singh Soin
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2018-08-31

5.  Ovarian Carcinoma Uncloaked by Hydatidosis: An Intraoperative Epiphany.

Authors:  Talal Almas; Tarek Khedro; Salman Hussain; Reema Alsufyani; Muhammad Kashif Khan
Journal:  Cureus       Date:  2020-10-31

6.  Radiofrequency Energy in Hepatic Bed during Partial Cystectomy for Hydatid Liver Disease: Standing Out from the Usual Conservative Surgical Management.

Authors:  Eleftherios Mantonakis; Alexandros Papalampros; Demetrios Moris; Nikolaos Dimitrokallis; Panagiotis Sakarellos; John Griniatsos; Evangelos Felekouras
Journal:  Gastroenterol Res Pract       Date:  2016-07-21       Impact factor: 2.260

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.